Abstracts are now being accepted for the above annual virtual conference, which brings together experts from the UK and around the world to share knowledge and discuss the latest developments in this field. This conference will provide a platform for researchers to present the latest findings in Group B Strep in pregnancy and babies, as well as an opportunity to network with peers and share best practices. We are particularly interested in research on GBS and epidemiology, vaccines, microbiology and testing, and clinical care relating to GBS in pregnant women and their newborns.
All accepted abstracts will have the opportunity to be published without charge (usual APC $1,700) in the SAGE peer-reviewed gold open access journal Therapeutic Advances in Infectious Disease, and up to four authors will be invited to pre-record a short presentation about their work for the conference. The submission deadline is midnight on Friday 10 March 2023.
There’s more information about the conference here and information about abstract submission here.